Probiotic E. coli treatment mediates antimicrobial human β-defensin synthesis and fecal excretion in humans
M Möndel(Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology), Jan Wehkamp(Robert Bosch Hospital), Sabine Nuding(Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology), Bjoern O. Schroeder(University of Gothenburg), Julia Beisner(Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology), Kurt Zimmermann(SymbioPharm (Germany)), Eduard F. Stange(John Radcliffe Hospital), H. Huber, Klaus Fellermann(Apple (Israel))
Cited by 157
Related Papers
Reduced Paneth cell α-defensins in ileal Crohn's disease
|Proceedings of the National Academy of Sciences|2005|969
NOD2 (CARD15) mutations in Crohn’s disease are associated with diminished mucosal α-defensin expression
|Gut|2004|798
A Chromosome 8 Gene-Cluster Polymorphism with Low Human Beta-Defensin 2 Gene Copy Number Predisposes to Crohn Disease of the Colon
|The American Journal of Human Genetics|2006|566
European evidence-based Consensus on the management of ulcerative colitis: Current management
|Journal of Crohn s and Colitis|2008|558